""
UC Davis Medicine Logo
The institution's principal publication for alumni, friends and physicians.
""
Horizontal boundary
""
""
"" "" ""
  N E W S  
"" "" ""
"" Stem cell research funding ""
""

""

""
"" Mechanism for attentional control found ""
""

""

""
"" Grant for FNP/PA program ""
""

""

""
  Cancer center network launched  
""

""

""
  Unusual toy use is autism clue  
""

""

""
  Key to aggressive breast cancer found  
""

""

""
  Environmental reasons for dating violence  
""

""

""
  Clue to unexplained deaths of epilepsy patients  
""

""

""
  Gates Foundation funds TB study  
""

""

""
  New telemedicine equipment loan program  
""

""

""
  Another antibiotic-overuse consequence  
""

""

""
  Molecule targeting brain tumors found  
""

""

""
  Reducing potential nerve damage  
""

""

""
  Starving pancreatic cancer cells  
""

""

""
  New IQ scoring for children with intellectual disabilities  
""

""

""
  UC Davis discovery offers hope for treating kidney cancer  
""

""

""
 

Diet cuts return of breast cancer in women without hot flashes

 
""

""

""
  Grant funds breast-cancer vaccine study  
""

""

""
  Nesbitt to help direct state telehealth services  
""

""

""
  Stem cell research collaboration  
Vertical Seperator Line
""
""
NEWS
""
""
"" ""
"" ""
 
""

Stem cell research collaboration

 "" PHOTO
"" ""

UC Davis Health System and Aldagen, a North Carolina biopharmaceutical company developing proprietary regenerative cell therapies, will collaborate on the planning and development of translational tools, models and technologies that eventually could lead to stem cell treatments for a variety of diseases and conditions, including ischemic stroke. Aldagen's technology isolates specific populations of adult stem cells that express high levels of aldehyde dehydrogenase. Preclinical studies have shown that these cells, which come from bone marrow and cord blood, may be able to repair neural tissue, thereby holding promise for the treatment of brain tissue damaged by ischemic stroke. Martha O'Donnell, professor of physiology and membrane biology, and Jan Nolta, director of the new UC Davis Institute for Regenerative Cures – a facility supported by the California Institute for Regenerative Medicine, will lead the ischemic stroke research component at UC Davis.

""
"" ""
 
"" ""
"" ""
Vertical Seperator Line
"" "" ""
     
"" "" Vertical Seperator Line "" "" "" ""
"" "" Vertical Seperator Line
""
""

UC DAVIS SCHOOL OF MEDICINE
PUBLIC AFFAIRS
4900 Broadway, Suite #1200
Sacramento, CA 95820

© 2009 UC Regents. All rights reserved.

"" "" ""